Clinical trial
Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors…
NCT00364676 · Spectrum Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT00364676 |
|---|---|
| Title | Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease |
| Official title | A Phase 1 Study of Vinorelbine Liposomes Injection (VLI) for Treatment in Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease |
| Lead sponsor | Spectrum Pharmaceuticals, Inc, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumors, Hodgkins Disease, Non-Hodgkins Lymphoma |
| Intervention type | Drug |
| Interventions | VLI |
| Enrollment | 67 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2015 |
| Completion | Aug 1, 2015 |
| First posted | Aug 16, 2006 |
| Last update posted | Sep 22, 2015 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: